14-day Premium Trial Subscription Try For FreeTry Free
£24.25
-1.00 (-3.96%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days £10.03 £37.80 Friday, 3rd May 2024 SAR.L stock ended at £24.25. This is 3.96% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.74% from a day low at £24.04 to a day high of £25.90.
90 days £10.00 £46.00
52 weeks £10.00 £149.00

Historical Sareum Holdings Plc prices

Date Open High Low Close Volume
Feb 10, 2016 £0.280 £0.335 £0.280 £0.295 84 735 667
Feb 09, 2016 £0.250 £0.280 £0.250 £0.280 73 471 685
Feb 08, 2016 £0.235 £0.250 £0.235 £0.250 8 906 778
Feb 05, 2016 £0.235 £0.235 £0.235 £0.235 2 127 814
Feb 04, 2016 £0.245 £0.245 £0.235 £0.235 4 609 935
Feb 03, 2016 £0.235 £0.265 £0.235 £0.245 12 022 059
Feb 02, 2016 £0.225 £0.265 £0.225 £0.245 28 039 043
Feb 01, 2016 £0.225 £0.235 £0.225 £0.225 6 811 562
Jan 29, 2016 £0.210 £0.220 £0.210 £0.220 2 264 867
Jan 28, 2016 £0.215 £0.215 £0.210 £0.210 4 875 850
Jan 27, 2016 £0.215 £0.215 £0.215 £0.215 4 955 193
Jan 26, 2016 £0.215 £0.215 £0.215 £0.215 1 281 040
Jan 25, 2016 £0.220 £0.220 £0.220 £0.220 5 614 446
Jan 22, 2016 £0.215 £0.220 £0.215 £0.220 5 018 318
Jan 21, 2016 £0.210 £0.215 £0.210 £0.215 4 669 737
Jan 20, 2016 £0.225 £0.225 £0.205 £0.210 16 987 947
Jan 19, 2016 £0.230 £0.230 £0.225 £0.225 1 314 261
Jan 18, 2016 £0.240 £0.240 £0.230 £0.230 1 988 019
Jan 15, 2016 £0.245 £0.245 £0.235 £0.240 1 882 356
Jan 14, 2016 £0.245 £0.245 £0.245 £0.245 2 333 465
Jan 13, 2016 £0.250 £0.250 £0.245 £0.245 6 202 741
Jan 12, 2016 £0.260 £0.260 £0.235 £0.250 17 168 893
Jan 11, 2016 £0.245 £0.265 £0.245 £0.260 22 058 089
Jan 08, 2016 £0.240 £0.255 £0.240 £0.245 30 610 151
Jan 07, 2016 £0.230 £0.255 £0.230 £0.240 26 700 993
Click to get the best stock tips daily for free!

About Sareum Holdings Plc

Sareum Holdings Plc Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering... SAR.L Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT